The Association for Accessible Medicines (AAM) recently announced that its president and CEO, Chip Davis, made a statement regarding the confirmation of Tom Price as Secretary of Health and Human Services. Read More »
Dr. Bernie Zeiher, president of development at Astellas Pharma, recently addressed the use of biomarkers in the development of precise and specific treatments for patients. Read More »
Prime Therapeutics releases report showing it held drug costs increases to just 2.5 percent for its clients in 2015. Read More »
Purdue Pharma LP has named Margaret Feltz vice president and chief ethics/compliance officer, reporting to President and CEO Mark Timney. Read More »
Takeda Pharmaceuticals U.S.A. Inc. recently welcomed Catherine Pugh, the mayor of Baltimore, to its Chicago office to celebrate Black History Month. Read More »
Sandoz, a Novartis Division, recently announced plans to double sales in Japan over the 2015 to 2022 period as part of a grander, longterm strategy to deliver better access to high quality medicines to the nation. Read More »
Precision for Value has named Dr. Maureen Hennessey, senior vice president and director of quality and population health systems, to the National Quality Forum’s Medicaid Innovation Accelerator Project 2016-2017. Read More »
Mark Jackson has been appointed vice president of Quality for Noven Pharmaceuticals Inc. Read More »
Spartanburg County, South Carolina has received a donation of opioid antidote. Read More »
RXi Pharmaceuticals Corp. has named Dr. Rolf Kiessling, professor in experimental oncology at Karolinska Institutet, to its Scientific Advisory Board. Read More »
"I'm thankful that we have the PBMs in the Part D program that are performing that negotiation on behalf of seniors." -- Seema Verma, nominee to serve as administrator of the Centers for Medicare and Medicaid Services Read More »
Lifes2good's new Berkeley Life Heart Health supplement, distributed by L2G North America Inc., is now available at Vitamin Shoppe and GNC stores across the country. Read More »
High prescription drug costs mean approximately 45 million adults in the U.S., or 18 percent of Americans over the age of 18, did not fill a prescription last year, according to the nonprofit group Prescription Justice.. Read More »
Biotechnology group Biogen presented this afternoon at the Leerink Partners' 6th Annual Global Healthcare Conference in New York. Read More »
The U.S. Food and Drug Administration approved Amgen's Parsabiv for the treating of secondary hyperparathyroidism in adults with chronic kidney failure and is administered at dialysis locations throughout the country. Read More »
Portola Pharmaceuticals cleared a U.S. Food and Drug Administration mid-cycle review for its new drug Betrixaban, meaning the drug will not have to go before an advisory committee at this stage. Read More »
A U.S. appeals court suspended a permanent injunction on Praluent, a cholesterol management drug, allowing Regeneron Pharmaceuticals to once again manufacture, market, sell and ship the drug around the world. Read More »
The newly rebranded Association for Accessible Medicines (AAM) recently launched a nationwide campaign with the mission of 'Keeping Medicines in Reach,' sharing patient profiles and maintaining its vision to control existing drug costs. Read More »
PharmaSmart International, a specialist in blood pressure kiosks, announced that its machines meet new Centers for Disease Control guidelines. Read More »
Soem critics argue that decades of U.S. Food and Drug Administration safeguards could be in jeopardy with President Donald Trump’s pick for head of the FDA. Read More »
Alerts Sign-up
